52 results
Page 2 of 3
6-K
EX-99.3
guq1c8f
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
1ym 6fvr04ef7h744j
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.3
kko qjyxo3
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
424B5
a5rr m37y0
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.2
3z22j7xid
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
424B8
gq2 r3ki7ql8m
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
uresdeqs4cq oc1
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.2
rkjpb
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-99.1
dhcxg6on n2
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-10.1
3nlfdmubzx9
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
sst9uchs
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-10.1
dukln8i6b8hb7w28a cb
17 May 19
Current report (foreign)
5:20pm
424B5
50crw0w
17 May 19
Prospectus supplement for primary offering
5:19pm
424B5
dxjh9xm0irwf80v8v0vn
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-1.1
qxo84ql3rwc208
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am